Akums Drugs and Pharmaceutical (AKUMS) — Net Asset Quality Index
Akums Drugs and Pharmaceutical (AKUMS) has a Net Asset Quality Index of 61.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Rs51.59 Billion minus total liabilities of Rs19.91 Billion yields net assets of Rs31.68 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Akums Drugs and Pharmaceutical liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Akums Drugs and Pharmaceutical Net Asset Quality Index Over Time (2022–2025)
This chart shows how Akums Drugs and Pharmaceutical's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 61.4%, representing net assets of Rs31.68 Billion against total assets of Rs51.59 Billion INR. See AKUMS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Akums Drugs and Pharmaceutical (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Akums Drugs and Pharmaceutical from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Akums Drugs and Pharmaceutical market cap and net worth.
| Year | Quality Index | Net Assets (INR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.5% | Rs30.64 Billion | Rs41.13 Billion | Rs10.50 Billion | ▲ +54.0 pp |
| 2024 | 20.5% | Rs7.20 Billion | Rs35.16 Billion | Rs27.96 Billion | ▼ -1.7 pp |
| 2023 | 22.1% | Rs7.23 Billion | Rs32.67 Billion | Rs25.43 Billion | ▲ +1.8 pp |
| 2022 | 20.4% | Rs6.25 Billion | Rs30.69 Billion | Rs24.44 Billion | — |